Name | 3,6-diamino-N-[(6E)-3-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide |
---|---|
Synonyms |
Tuberactinomycin N
Tuberactinomycin A Tuberactinomycin Viomycin,1-(L-threo-3,6-diamino-4-hydroxyhexanoic acid) (3R,4R)-3,6-diamino-4-hydroxy-hexanoyl->-cyclo-[L-2,3-diamino-propionyl->-L-seryl->-L-seryl->-(Z)-2-amino-3-ureido-acryloyl->-(S)-amino-((R)-2-amino-1(3),4,5,6-tetrahydro-pyrimidin-4-yl)-acetyl-(1->N3)] C25H43N13O11 1-(L-threo-3,6-Diamino-4-hydroxyhexanoic acid)viomycin 3,6-diamino-4-hydroxy-hexanoyl->-cyclo-[L-2,3-diamino-propionyl->-L-seryl->-L-seryl->-2-amino-3-ureido-acryloyl->-(S)-amino-((4R)-2-amino-6t-hydroxy-1(3),4,5,6-tetrahydro-pyrimidin-4r-yl)-acetyl-(1->N3)] |
Description | Enviomycin (Tuberactinomycin N) is a antibacterial antibiotic. Enviomycin has been used to research chronic cavitary pulmonary tuberculosis[1]. |
---|---|
Related Catalog | |
Target |
Mycobacterium tuberculosis[1] |
In Vitro | Enviomycin has antibacterial activity against Mycobacterium tuberculosis strain H37Rv, Mycobacterium avium-Mycobacterium intracellulare complex (MAI complex) strains 13008, 13016 and 11004 with MICs of 12.5 μg/mL, 3.2 μg/mL, 6.3 μg/mL, 12.5 μg/mL, respectively[1]. |
Density | 1.8g/cm3 |
---|---|
Molecular Formula | C25H43N13O10 |
Molecular Weight | 685.69000 |
Exact Mass | 685.32600 |
PSA | 412.29000 |
Index of Refraction | 1.762 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|